FRI in critical care: challenges and opportunities Functional Respiratory Imaging (FRI) did not have a place in critical care before the COVID-19 pandemic, but as healthcare systems were overloaded with... View Article
In a recently published systematic literature review, members of PVRI Innovative Drug Development Initiative’s Sequelae of COVID-19 Workstream, including Fluidda CEO Jan De Backer and CSO Ben Lavon, sought to... View Article
The potential of FRI in General Pulmonology “Technological advances have unleashed the potential to better treat prevalent lung diseases. Approaches like quantitative computerized tomography are increasingly used in routine care... View Article
The Medimprove pulmonary rehabilitation facility, affiliated with Fluidda, is located in Kontich, Belgium.This interview with a COVID patient treated in this practice is therefore in Dutch language. Auteur: Patrick Marx... View Article
Imaging of the pulmonary vasculature is crucial for our understanding of the short- and long-term consequences of COVID-19 Prof. William Li, president and medical director of the Angiogenesis Foundation, explains during an interview in... View Article
In a recently published study Functional Respiratory Imaging (FRI) was used to retrospectively study the association of abnormal pulmonary vasculature on CT scan for COVID-19 infection with decreased diffusion capacity in follow... View Article
Presentation CEO Fluidda at DDL 2021 conference: Functional Respiratory Imaging in times of COVID19 Tomorrow, December 9, Fluidda’s CEO Jan De Backer will present at the virtual conference Drug delivery... View Article
FRI used to understand the link between pulmonary vasculature abnormalities and DCLO in COVID-19 In a recent article, Prof Daniel Salerno, Prof Victor Kim and colleagues used Functional Respiratory Imaging to better understand the crucial... View Article
Fluidda’s vascular lung images featured on the cover of the digital European Respiratory Journal The European Respiratory Journal published a study (ERJ, impact factor 16.67) looking at the pulmonary blood... View Article
Johan Clukers, Maarten Lanclus, Dennis Belmans, Cedric Van Holsbeke, Wilfried De Backer, Dharshan Vummidi, Paul Cronin, Ben R Lavon, Jan De Backer and Dinesh Khanna